Trial Profile
ASP015K Pharmacokinetic Study - Bioequivalence Evaluation of a Small and Current Tablet of ASP015K
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 27 Aug 2015 New trial record